• LAST PRICE
    0.6738
  • TODAY'S CHANGE (%)
    Trending Up0.0321 (5.0022%)
  • Bid / Lots
    0.6500/ 24
  • Ask / Lots
    0.8000/ 1
  • Open / Previous Close
    0.6680 / 0.6417
  • Day Range
    Low 0.6250
    High 0.8201
  • 52 Week Range
    Low 0.4300
    High 1.6800
  • Volume
    128,401
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.6417
TimeVolumeVIRX
09:32 ET2300.668
09:36 ET5000.6251
09:39 ET6500.6475
10:03 ET2000.632
10:06 ET59790.625
10:14 ET4550.6484
10:30 ET5470.652
10:35 ET20000.668823
10:42 ET487610.7808
10:44 ET264640.74
10:46 ET1000.74
10:48 ET2000.7178
10:50 ET15860.6615
10:55 ET2000.7031
10:57 ET10120.6915
11:08 ET11000.69
11:22 ET5000.69
11:26 ET1000.7124
11:38 ET40400.6908
11:51 ET13560.6503
12:14 ET2570.673
12:23 ET2000.65
12:45 ET8340.68
12:52 ET2630.6551
12:54 ET15000.655101
01:03 ET4000.6551
01:08 ET8210.655
01:30 ET35200.6799
01:32 ET20000.6775
01:53 ET2000.6775
02:00 ET9990.6601
02:04 ET21000.6605
02:08 ET66000.6551
02:18 ET5000.65
02:22 ET50000.654
02:44 ET2410.654
02:47 ET1700.6541
03:21 ET2000.6749
03:27 ET1000.674
03:39 ET1000.6749
03:56 ET2000.6749
03:57 ET8820.675
03:59 ET2980.6738
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVIRX
Viracta Therapeutics Inc
26.5M
-0.5x
---
United StatesBIOR
Biora Therapeutics Inc
26.8M
-0.1x
---
United StatesABTI
Alterola Biotech Inc
27.3M
-7.5x
---
United StatesJAN
Janone Inc
27.5M
-0.6x
---
United StatesBIVI
BioVie Inc
28.1M
-0.5x
---
United StatesRNXT
RenovoRx Inc
28.3M
-1.6x
---
As of 2024-06-15

Company Information

Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers, which impact patients worldwide. The Company’s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively, Nana-val). Nana-val is being evaluated in multiple ongoing clinical trials, including a pivotal, global, multicenter, open-label Phase II basket trial for the treatment of multiple subtypes of relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) lymphoma (NAVAL-1), as well as a multinational, open-label Phase Ib/II clinical trial for the treatment of patients with recurrent or metastatic (R/M) EBV + nasopharyngeal carcinoma (NPC) and other advanced EBV + solid tumors. The Company is also pursuing the application of its Kick and Kill approach in other virus-related cancers.

Contact Information

Headquarters
2533 S COAST HWY 101, SUITE 210CARDIFF BY THE SEA, CA, United States 92007
Phone
858-400-8470
Fax
650-266-3501

Executives

Independent Chairman of the Board
Roger Pomerantz
President, Chief Executive Officer, Director
Mark Rothera
Chief Financial Officer
Michael Faerm
Senior Vice President - Finance
Melody Burcar
Chief Medical Officer
Darrel Cohen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$26.5M
Revenue (TTM)
$0.00
Shares Outstanding
39.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.76
EPS
$-1.24
Book Value
$0.47
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.